Statements Author contributions MJ: Visualization, Conceptualization, Writing original draft, Writing review & editing
Related Pages Insights Library Further reading
Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent
Angela Fitch, former director of the Massachusetts General Hospital Weight Center, called the sale of compounded GLP-1 weight loss medication the largest uncontrolled, unconsented human experiment of our lifetime. What scares me more than the unnerving (and disgusting) potential side effects of the latest miracle drug is the cultural repositioning of weightan incredibly complex, multi-faceted problem specific to each individualas something that can be medicated away, until all human bodies morph into one Great, Perfect Body (or risk social censure)
CJC-1295 No DAC is not FDA-approved for any use
.png.jpg)
